Toggle Main Menu Toggle Search

Open Access padlockePrints

Recent advances in diabetic nephropathy

Lookup NU author(s): Emerita Professor Sally Marshall


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Diabetic nephropathy is the leading cause of end stage renal disease worldwide and is associated with increased cardiovascular risk. The earliest clinical manifestation is of microalbuminuria. Tight blood glucose and blood pressure control reduce the risk of microalbuminuria. Once microalbuminuria is present, the rate of progression to end stage renal disease and of cardiovascular disease can be delayed by aggressive management of blood pressure, glucose, and lipids. Inhibition of the renin-angiotensin system is important to reduce intraglomerular pressure but other classes of antihypertensive agent may also be needed to gain adequate control of systemic blood pressure. Such measures can at least half the rate of progression of nephropathy and cardiovascular disease.

Publication metadata

Author(s): Marshall SM

Publication type: Review

Publication status: Published

Journal: Postgraduate Medical Journal

Year: 2004

Volume: 80

Issue: 949

Pages: 624-633

ISSN (print): 0032-5473

ISSN (electronic): 1469-0756


DOI: 10.1136/pgmj.2004.021287

PubMed id: 15537844